News for FTRPF Stock

Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP" Field Trip Health Ltd. to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021 Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd. More than 80% of Americans report one or more symptoms of depression, and many have turned to substances to cope with negative emotions during COVID-19 Pandemic, according to Field Trip Health’s First Annual “State of Mind” Survey Field Trip Health Ltd. Announces DTC Eligibility Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica